ICMR & Hyderabad-based Indian Immunologicals come together to develop vaccine for vector-borne disease being seen as emerging ...

In The Lancet Infectious Diseases, Fernando Abad-Franch and colleagues1 present the results of a study that used distributions in case data to assess the effect of mosquito-disseminated pyriproxyfen ...

The Cell & Gene Therapy Manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

Furthermore, beyond the immediate trial, there is a broader potential for approval and product launches from Rocket’s lentiviral vector-based therapies, which adds to the investment case. The Phase 2 ...

SOMERVILLE, N.J. – A Somerset County jury convicted Victor Ogando-Marte, 39, from Plainfield, of third-degree aggravated ...

The future of CRISPR involves clinical trials focused on treatment for blood diseases and cancers, cardiovascular disease, ...

The US Department of Agriculture (USDA) has taken a significant step towards the approval of an H5N1 avian flu vaccine for ...

Delve into Vironexis' launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...

Given spike in vector-borne disease cases, PMC has launched a case-concentrated containment initiative across the city ...

The company said the single-arm multicenter Phase II trial may support accelerated approval for the RP-A501 gene therapy in the US.